CD44 and CHARGE syndrome: Similar results were obtained when assessing alternative splicing of Cd44, a known splicing target of AGO2 (14) that we also found to be dysregulated by the loss of either of the CHARGE syndrome-associated proteins FAM172A or CHD7 (4).